Evidence map›Paper›PMID 38672625›Full record

ArticleCancers2024

Predicting Isocitrate Dehydrogenase Status in Non-Contrast-Enhanced Adult-Type Astrocytic Tumors Using Diffusion Tensor Imaging and

Shoji Yasuda, Hirohito Yano, Yuka Ikegame, Soko Ikuta, Takashi Maruyama, Morio Kumagai, Yoshihiro Muragaki, Toru Iwama, Jun Shinoda, Tsuyoshi Izumo

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Evaluation of [Journal of clinical medicine · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Shoji YasudaDepartment of Neurosurgery, Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Minokamo 505-0034, Japan.ORCID 0009-0001-7191-4841
Hirohito YanoDepartment of Neurosurgery, Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Minokamo 505-0034, Japan.ORCID 0000-0002-4252-4780
Yuka IkegameDepartment of Neurosurgery, Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Minokamo 505-0034, Japan.ORCID 0000-0002-8932-9798
Soko IkutaDepartment of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Takashi MaruyamaDepartment of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Morio KumagaiDepartment of Neurosurgery, Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Minokamo 505-0034, Japan.
Yoshihiro MuragakiDepartment of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Toru IwamaDepartment of Neurosurgery, Gifu Municipal Hospital, Gifu 500-8513, Japan.ORCID 0000-0002-9426-284X
Jun ShinodaDepartment of Neurosurgery, Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Minokamo 505-0034, Japan.
Tsuyoshi IzumoDepartment of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.ORCID 0000-0001-8778-2698
Gifu University · JPTokyo Women's Medical University · JPGifu Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to differentiate the isocitrate dehydrogenase (IDH) status among non-enhanced astrocytic tumors using preoperative MRI and PET. We analyzed 82 patients with non-contrast-enhanced, diffuse, supratentorial astrocytic tumors (IDH mutant [IDH-mut], 55 patients; IDH-wildtype [IDH-wt], 27 patients) who underwent MRI and PET between May 2012 and December 2022. We calculated the fractional anisotropy (FA) and mean diffusivity (MD) values using diffusion tensor imaging. We evaluated the tumor/normal brain uptake (T/N) ratios using

Indexed as

astrocytomadiffusion tensor imagingglioblastomagliomaisocitrate dehydrogenase mutationpositron emission tomography

Identifiers

PMID38672625
PMCPMC11048577
OpenAlexW4394931770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.